National and Kapodistrian University of Athens
Επιδημιολογική διερεύνηση της αντοχής σε λοιμώξεις από gram-αρνητικά αναερόβια βακτήρια και διερεύνηση των μηχανισμών αντοχής με φαινοτυπική και γονοτυπική μεθοδολογία
Abstract
dc:descriptionThe purpose of the study was the investigation of the epidemiology and the resistance percentage and mechanisms of Gram negative anaerobic clinical isolates from patients of several tertiary hospitals in Athens. Material: A total of 330 Gram negative anaerobic bacteria were isolated from hospitals of Athens, during the period January 2003 - June 2006, and epidemiological and clinical information were collected for 206 of those: gender, age, ward type, duration of hospitalization, underlying disease, clinical manifestation, outcome, prior antimicrobial therapy, infection treatment, and microbiological data (clinical specimen, species identification, other pathogens from the same specimen). Methods: The isolation and identification of the isolates was performed according to routine protocols of each microbiology laboratory. Susceptibility testing to penicillin, cefoxitin, ticarcillin+clavulanic acid, piperacillin+tazobactam, clindamycin, imipenem, metronidazole, tetracycline and ertapenem was performed with E-test technique. Tigecycline and moxifloxacin MIC determination was performed with agar dilution. Presence of cfiA and nim genes, which are involved to the resistance mechanisms of carbapenems and metronidazole, respectively, was detected by a PCR method. Analysis of the clinical and epidemiological data was performed with the STATA 6.0 program. Results: From the 330 isolates, 196 were identified as Bacteroides fragilis group, 36 as non-fragilis Bacteroides spp., 62 as Prevotella spp., 19 as Fusobacterium spp., 7 as Porphyromonas spp. and 8 as Veillonella spp. The total resistance rates to penicillin, ticarcillin+clavulanic acid, piperacillin+tazobactam, cefoxitin, imipenem, clindamycin, metronidazole and tetracycline were are 79%, 1%, 1%, 9%, 0%, 23%, 3% and 55%, respectively. Bacteroides fragilis group rates were 96%, 3%, 2%, 14%, 1%, 22%, 0% and 63%, respectively. Bacteroides spp. non fragilis resistance rates were 86%, 0%, 0%, 2%, 0%, 27%, 0% and 70%, respectively. Prevotella spp. resistance rates were 62%, 0%, 0%, 0%, 0%, 22%, 12% και 39%, respectively. The overall resistance rates to ertapenem was 3.8%, whereas among Bacteroides fragilis group, Bacteroides spp. non fragilis and Prevotella spp. were 5,1%, 6,3% and 0%, respectively. The overall resistance rates to tigecycline was 3%, while among Bacteroides fragilis group, Bacteroides spp. non fragilis and Prevotella spp. were 3%, 11% and 0%, respectively. As far as moxifloxacin is concerned, MIC90 of all different groups (total, B. fragilis group, Bacteroides spp. non fragilis and Prevotella spp.) were >32mg/L. Nim genes were detected in both metronidazole resistant and susceptible isolates, as well as in all genus of Gram negative anaerobic bacteria. CfiA genes were found in 6 of 7 carbapenem resistant isolates and are considered the most common resistance mechanism concerning carbapenems, in this study. Among polymicrobial infections an association was detected between Staphylococcus and Prevotella spp., and between Enterobacteriaeae and Bacteroides spp. Indepedently associated risk factors for mortality from Gram negative anaerobic infections were haematological malignancy, solid organ neoplasm and bacteremia. Conclusions: Carbapenems, b-lactam+inhibitor and metronidazole are considered excellent therapeutic choices for the treatment of Gram negative anaerobic infections. Epidemiological and clinical differences were detected among cases of infections due to different Gram negative anaerobic species, differences that provide useful information for the optimization of the respective empirical treatment guidelines. At the same time, nim and cfiA genes which confer resistance to metronidazole and carbapenems, respectively were detected
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Katsandri, Anastasia
- Κατσανδρή, Αναστασία
Subjects
dc:subject × 20- Βακτήρια gram-ανητικά
- Ποσοστά αντοχής
- Τιγεκυκλίνη
- Μοξιφλοξασίνη
- Ερταπενέμη
- Γονίδια, NIM
- Γονίδια, CFIA
- Επιδημιολογία
- Gram negative bacteria
- Resistance percentage
- Tigecycline
- Moxifloxacin
- Ertapenem
- Genes, NIM
- Genes, CFIA
- Epidemiology
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19335